Dr. Landen Discusses P53 Mutations In Ovarian Cancer

Dr. Landen Discusses p53 Mutations in Ovarian Cancer

Dr. Landen on Molecular Subtypes of Ovarian Cancer

Dr. Memarzadeh on p53 Reactivation in Ovarian Cancer

Dr. McCann on Resistance Mutations in Ovarian Cancer

Dr. Powell on Tumor Mutational Burden in Ovarian Cancer

Fibronectin and mutant p53 gene make for deadly duo in ovarian carcinomas

AJE Video Bytes

Dr. Shah Discusses P53-Mutated Mantle Cell Lymphoma

Dr. Rule on Patients With p53-Mutated MCL

The Truth About Hormones, Menopause and Breast Cancer! Dr Corinne Menn

All About You With Dr Shauna Watts

Dr. Borst on Homologous Recombination Deficiency in Patients With Ovarian Cancer

First-in-class Wee1 inhibitor AZD1775 shows promise against p53 mutated ovarian cancers

Dr. Muggia Discusses the Impact of BRCA Mutations in Ovarian Cancer

Targeted Oncology

Dr. Kurian on Linking Ovarian Cancer Risk With Mutations From Multiple-Gene Germline Sequencing

Overcoming the barriers of the P53 dysfunction to cure blood cancers

Somatic Mutation Testing for Ovarian Cancer

Dr. Salani Discusses Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in Ovarian Cancer

Aziz Nazha, MD: How Do TP53 Mutation Characteristics Affect MDS Outcomes?

American Society of Hematology

Dr. Zsiros Discusses Pembrolizumab Triplet in Recurrent Ovarian Cancer

Understanding Genetic Mutations and Biomarkers in Ovarian Cancer

You and Ovarian Cancer

Dr. Elhassadi Discusses the Outlook of Patients With p53-Mutated MCL